Zentek Stock (NASDAQ:ZTEK)


OwnershipChart

Previous Close

$0.44

52W Range

$0.40 - $1.37

50D Avg

$0.57

200D Avg

$0.70

Market Cap

$44.40M

Avg Vol (3M)

$141.94K

Beta

0.32

Div Yield

-

ZTEK Company Profile


Zentek Ltd., a Canadian enterprise, specializes in the exploration and advancement of graphene alongside other related nanomaterials. The company holds full ownership of the Albany Graphite project, an important asset located in Northern Ontario, Canada. Leveraging its expertise, Zentek creates a variety of graphene-based products, including the ZenGUARD™ brand antimicrobial coating, enhanced surgical masks, advanced HVAC filtration systems, and various forms of personal protective equipment. Additionally, they are developing rapid point-of-care diagnostic tests and pharmaceutical products utilizing graphene compounds. Beyond these applications, the company also manufactures fundamental forms of graphene, graphene oxide, and graphene quantum dots for diverse industrial uses. Established in 2008, the company adopted its current name, Zentek Ltd., in October 2021, having previously been known as ZEN Graphene Solutions Ltd. Its corporate headquarters are situated in Thunder Bay, Canada.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

24

IPO Date

Apr 02, 2012

Website

ZTEK Performance


Peer Comparison


TickerCompany
HYFTMindWalk Holdings Corp.
MBOTMicrobot Medical Inc.
QNCXQuince Therapeutics, Inc.
BYSIBeyondSpring Inc.
AMWLAmerican Well Corporation
CRDLCardiol Therapeutics Inc.
GUTSFractyl Health, Inc. Common Stock
MGXMetagenomi, Inc. Common Stock
ALXOALX Oncology Holdings Inc.
HYPRHyperfine, Inc.